Chemoinformaics analysis of 6-METHOXYFURO[2,3-H]CHROMEN-2-ONE
| Molecular Weight | 216.192 | nRot | 1 |
| Heavy Atom Molecular Weight | 208.128 | nRig | 16 |
| Exact Molecular Weight | 216.042 | nRing | 3 |
| Solubility: LogS | -3.557 | nHRing | 2 |
| Solubility: LogP | 1.971 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 15 |
| nHA | 4 | APOL | 28.5823 |
| nHD | 0 | BPOL | 14.1017 |
| QED | 0.586 |
| Synth | 2.505 |
| Natural Product Likeliness | 1.324 |
| NR-PPAR-gamma | 0.177 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.018 |
| HIA | 0.009 |
| CACO-2 | -4.756 |
| MDCK | 0.0000319 |
| BBB | 0.049 |
| PPB | 0.796863 |
| VDSS | 0.917 |
| FU | 0.149143 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.905 |
| CYP2c19-inh | 0.547 |
| CYP2c19-sub | 0.095 |
| CYP2c9-inh | 0.273 |
| CYP2c9-sub | 0.809 |
| CYP2d6-inh | 0.803 |
| CYP2d6-sub | 0.785 |
| CYP3a4-inh | 0.805 |
| CYP3a4-sub | 0.2 |
| CL | 12.973 |
| T12 | 0.759 |
| hERG | 0.008 |
| Ames | 0.308 |
| ROA | 0.382 |
| SkinSen | 0.185 |
| Carcinogencity | 0.906 |
| EI | 0.081 |
| Respiratory | 0.93 |
| NR-Aromatase | 0.778 |
| Antiviral | No |
| Prediction | 0.629918 |